Circulating Tumor Cells (CTCs) are cells that have detached from the primary tumor and flow into the blood or lymphatic circulation creating a secondary tumor. Despite their rare population, these cells exhibit metastatic attributes and are related to cancer progression.
The R.G.C.C test is a test for patient’s seeking personalised cancer testing where it has the ability to:
-Detect early signs of developing cancer
-Help monitoring existing cancers
-Produce an individual profile of chemotherapeutic drugs and natural substances that can be used to achieve the best treatment outcomes.
Onconomics Plus: Provides information about the efficacy of specific drugs on the cancer cells derived from a single patient. The method incorporates two procedures (epigenetic analysis and viability assays) to validate the data. The efficacy of natural biological substances or extracts on cancer cells is also referred to. The assessment is based on three methods: the direct cytotoxic effect, stimulation of the immune system and the inhibition of proliferative signals in the cancer cells.
About The Test
All tests come with full instructions, including a pre-authorised practitioner script.
Home test kits come with everything you need to complete the test, including free express post return postage to the laboratory.
All pathology test kits come with a preauthorised script (including test kit/s if required) to take to your local pathology test centre.
You can click here to find a pathology near you.
Turn-around time: 14 days
Sample Reports are available by clicking on the following link: R.G.C.C Sample Report
